Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.
James Moray

Share this

We are delighted to announce the latest team member at Charnwood Molecular, Dr James Morey, who joins us as Head of Process Research and Development.

After graduating with an MChem from UMIST (now the University of Manchester) in 2001, James began his career as a bench chemist within the Discovery Research Division at GlaxoSmithKline. He made several important contributions in declaring tractable lead series for high-profile kinase targets. Three years later, the opportunity to pursue a PhD at the University of Cambridge in main-group organometallic chemistry applied to organic synthesis, kindled his interest in understanding chemical reactions intimately and using this knowledge to engineer optimal outcomes in complex synthetic routes.

After a brief stint back in a Medicinal Chemistry role (Lead Optimisation), James carried out research and development into the challenging area of novel blue polymer-organic light emitting diodes (P-OLED’s) which augmented his practical experience of Process Research and Development in an industrial setting.

After 13 years laboratory experience, James became Technical Director and a Board member at ProSynth Ltd, with overall responsibility for quoting, project management and delivery of custom synthesis projects ranging from mg to kg scales.